[go: up one dir, main page]

AU3282700A - Solution for injection for the treatment of arthroses - Google Patents

Solution for injection for the treatment of arthroses

Info

Publication number
AU3282700A
AU3282700A AU32827/00A AU3282700A AU3282700A AU 3282700 A AU3282700 A AU 3282700A AU 32827/00 A AU32827/00 A AU 32827/00A AU 3282700 A AU3282700 A AU 3282700A AU 3282700 A AU3282700 A AU 3282700A
Authority
AU
Australia
Prior art keywords
solution
treatment
injection
arthroses
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32827/00A
Inventor
Chakravarty Adusumalli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7899024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU3282700(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU3282700A publication Critical patent/AU3282700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to a solution for injection containing a mixture of a solution A of a gold compound and a solution B of a calendula extract and belladonna extract. The invention also relates to the use of such a solution for injection for the treatment of arthroses as well as to a kit containing a solution A and a solution B. The invention further relates to the use of a dextran solution for the irrigation of joints. The solution for injection provided for by the invention can be used for the treatment of arthroses in a manner which preserves the joints. Treatment is successful in approximately 85 % of cases so that more extensive surgery and arthroplastic intervention becomes unnecessary.
AU32827/00A 1999-02-26 2000-02-25 Solution for injection for the treatment of arthroses Abandoned AU3282700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19908441 1999-02-26
DE19908441A DE19908441C1 (en) 1999-02-26 1999-02-26 Injection solution for the treatment of arthrosis
PCT/EP2000/001602 WO2000050045A2 (en) 1999-02-26 2000-02-25 Solution for injection containing a gold compound, calendula and belladonna extracts for the treatment of arthroses

Publications (1)

Publication Number Publication Date
AU3282700A true AU3282700A (en) 2000-09-14

Family

ID=7899024

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32827/00A Abandoned AU3282700A (en) 1999-02-26 2000-02-25 Solution for injection for the treatment of arthroses

Country Status (5)

Country Link
EP (1) EP1156810B1 (en)
AT (1) ATE266414T1 (en)
AU (1) AU3282700A (en)
DE (2) DE19908441C1 (en)
WO (1) WO2000050045A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163676A1 (en) * 2001-12-21 2003-07-10 Phenion Gmbh & Co Kg Use of Hyperforin or extracts from St. John's wort against anaphylactic shock or osteoporosis
US7115563B2 (en) 2002-05-29 2006-10-03 Insignion Holding Limited Composition and its therapeutic use
DE102006054653A1 (en) * 2006-11-17 2008-05-21 Ada Cosmetic Gmbh Body or beauty care products
WO2010133707A1 (en) * 2009-05-18 2010-11-25 Asac Compañía De Biotecnología E Investigación Sa Stabilized hyperforin solutions for oral administration
EP3573633A1 (en) * 2017-01-26 2019-12-04 Aboca S.p.A. Societa' Agricola New compositions for the treatment of articular disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1243957A (en) * 1983-06-03 1988-11-01 Laszlo Bogdany Compositions for cosmetic, health- and body- preserving use
US6379714B1 (en) * 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
FR2733419B1 (en) * 1995-04-27 1997-08-08 Blackborough Ltd PLANT EXTRACTS, THEIR MANUFACTURING PROCESS, PHYTOPROTEIC CONJUGATES CONTAINING THEM AND THEIR APPLICATIONS
DE19544905A1 (en) * 1995-12-01 1997-06-05 Robugen Gmbh Preparation of plant extracts
US5840290A (en) * 1996-05-30 1998-11-24 University Of Florida Research Foundation Injectable bio-active glass in a dextran suspension
US5902800A (en) * 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders

Also Published As

Publication number Publication date
ATE266414T1 (en) 2004-05-15
WO2000050045A3 (en) 2000-11-16
DE19908441C1 (en) 2000-08-31
DE50006409D1 (en) 2004-06-17
EP1156810A2 (en) 2001-11-28
WO2000050045A2 (en) 2000-08-31
EP1156810B1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
AU2001273094A1 (en) Compounds to treat alzheimer's disease
DE69531457D1 (en) Sulfonamide
GEP20032922B (en) Benzoheterocycles and Their Use as MEK Inhibitors
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2002002520A8 (en) Compounds to treat alzheimer's disease
AU2001252958A1 (en) Compounds and methods to treat alzheimer's disease
WO2001052921A3 (en) Valve arrangement
WO1994012219A3 (en) Modified insulin-like growth factors
MXPA04004548A (en) Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors.
BG103096A (en) Thrombin inhibitors
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
AU2115695A (en) L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
SG48298A1 (en) Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
WO2001081332A3 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
NZ516290A (en) Substituted phenoxyacetic acids
AU2634597A (en) Compounds with growth hormone releasing properties
AU3282700A (en) Solution for injection for the treatment of arthroses
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
AU2003271811A1 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
AU2420001A (en) Methods and compositions for the treatment of pain
AU2566101A (en) Compounds and methods for the treatment of pain
WO2004029019A8 (en) Compounds for the treatment of alzheimer’s disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase